NASDAQ:JAZZ

Jazz Pharmaceuticals Stock Insider Trading

Healthcare > Biotechnology

Buy JAZZ

*Your capital is at risk

$230.93

+4.81 (+2.13%)

At Close: Jun 03, 2026

Jazz Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -67.51. In total, the insiders bought 504.67K and sold 290.36K JAZZ shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-67.51
● Buy	504.67K shares
● Sell	290.36K shares
43% Buy Activity Negligible or No Correlation
Sell Signal Medium Confidence Feb 26, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -67.51. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Dec 05, 2025 Buy	Non-Qualified Stock Option (right to buy) M-Exempt	Carr Patricia SVP, Chief Accounting Officer	Officer	4 500 Value: $633.0K
Dec 05, 2025 Sell	Ordinary Shares F-InKind	Gala Renee D President & CEO	CEO / President	80 Value: $13.4K
Dec 02, 2025 Sell	Ordinary Shares F-InKind	O'keefe Kenneth W Director	Director	603 Value: $104.4K
Dec 01, 2025 Buy	Common Stock J-Other	Love Ted W	Director	0 Value: $0
Nov 26, 2025 Buy	Incentive Stock Option (right to buy) M-Exempt	Cozadd Bruce C Director	Director	811 Value: $100.0K
Nov 26, 2025 Sell	Ordinary Shares S-Sale	Cozadd Bruce C Director	Director	38 126 Value: $6.76M
Nov 26, 2025 Sell	Ordinary Shares S-Sale	Cozadd Bruce C Director	Director	8 380 Value: $1.50M
Nov 26, 2025 Sell	Ordinary Shares S-Sale	Cozadd Bruce C Director	Director	30 487 Value: $5.43M
Nov 26, 2025 Buy	Ordinary Shares M-Exempt	Cozadd Bruce C Director	Director	76 689 Value: $9.46M
Nov 26, 2025 Buy	Ordinary Shares M-Exempt	Cozadd Bruce C Director	Director	811 Value: $100.0K
Nov 26, 2025 Sell	Ordinary Shares S-Sale	Cozadd Bruce C Director	Director	507 Value: $91.2K
Nov 26, 2025 Buy	Non-Qualified Stock Option (right to buy) M-Exempt	Cozadd Bruce C Director	Director	76 689 Value: $9.46M
Nov 20, 2025 Buy	Ordinary Shares M-Exempt	Mcsharry Heather Ann Director	Director	3 415 Value: $471.5K
Nov 20, 2025 Sell	Ordinary Shares S-Sale	Mcsharry Heather Ann Director	Director	3 415 Value: $607.1K
Nov 20, 2025 Buy	Non-Qualified Stock Option (right to buy) M-Exempt	Mcsharry Heather Ann Director	Director	3 415 Value: $471.5K
Nov 20, 2025 Buy	Ordinary Shares A-Award	Cozadd Bruce C Director	Director	2 506 Value: $440.4K
Nov 19, 2025 Sell	Ordinary Shares D-Return	Henderson Mary Elizabeth SVP, Technical Operations	Officer	1 331 Value: $240.1K
Nov 18, 2025 Sell	Ordinary Shares S-Sale	Cozadd Bruce C Director	Director	717 Value: $130.9K
Nov 18, 2025 Sell	Ordinary Shares S-Sale	Cozadd Bruce C Director	Director	5 517 Value: $1.00M
Nov 18, 2025 Sell	Ordinary Shares S-Sale	Cozadd Bruce C Director	Director	8 382 Value: $1.52M
Nov 18, 2025 Sell	Ordinary Shares S-Sale	Cozadd Bruce C Director	Director	3 384 Value: $609.4K
Nov 18, 2025 Buy	Ordinary Shares M-Exempt	Carr Patricia SVP, Chief Accounting Officer	Officer	5 250 Value: $714.9K
Nov 18, 2025 Buy	Non-Qualified Stock Option (right to buy) M-Exempt	Carr Patricia SVP, Chief Accounting Officer	Officer	5 250 Value: $714.9K
Nov 18, 2025 Sell	Ordinary Shares S-Sale	Winningham Rick E Director	Director	5 500 Value: $994.7K
Aug 18, 2025 Sell	Ordinary Shares J-Other	Enright Patrick G Director	Director	5 000 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT JAZZ PHARMACEUTICALS PLC

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic and solid tumors. Its lead marketed products include ...

Read Full Profile Here